Search results
Taysha Gene Therapies’ (TSHA) “Buy” Rating Reaffirmed at Needham & Company LLC
ETF DAILY NEWS· 12 hours agoTaysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a research report issued to clients ...
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Down 4.1%
ETF DAILY NEWS· 2 days agoTaysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) traded down 4.1% on Friday . The company traded as low as $3.95 and last traded at $4.00. 191,240 shares were traded ...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 4 days agoFurther, Pfizer's gene therapy has been tied to safety issues. In this study, Pfizer says most...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 1.9%
ETF DAILY NEWS· 2 days agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price was down 1.9% during trading on Friday . The company traded as low as $63.77 and last traded at $64.04 ...
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock
Market Watch· 4 days agogained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a...
Immutep (NASDAQ:IMMP) Stock Price Crosses Above 50 Day Moving Average of $2.74
ETF DAILY NEWS· 3 days agoShares of Immutep Limited (NASDAQ:IMMP – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of ...
Stoke Therapeutics (NASDAQ:STOK) Shares Gap Down to $17.52
ETF DAILY NEWS· 2 days agoStoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s stock price gapped down prior to trading on Friday . Stoke Therapeutics shares last traded at ...
Why Gene Munster thinks Apple can go meaningfully higher By Investing.com
Investing.com· 4 days agoApple (AAPL) stock has the potential to “meaningfully go higher,” according to Deepwater Asset...
Genetic Technologies Limited (NASDAQ:GENE) Short Interest Up 495.3% in May
ETF DAILY NEWS· 4 days agoGenetic Technologies Limited (NASDAQ:GENE – Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short ...
Alnylam Pharmaceuticals Unusual Options Activity For June 17 - Alnylam Pharmaceuticals (NASDAQ:ALNY)
Benzinga· 2 hours agoAlnylam has five drugs on the market: Onpattro and Amvuttra for hATTR...Standing of Alnylam Pharmaceuticals With a trading volume of 345,641, the price of ALNY is down by ...